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Abbreviations
HRV  heart rate variability
METS  metabolic equivalents
CRP  C-reactive protein
MOD  moderate group
VIG  vigorous group
RR   time between QRS complexes in electrocardiography
MRS  Menopause Rating Scale
PSS  Perceived Stress Scale
HT   hormone therapy
SDNN  standard deviation of normal to normal RR intervals
rMSSD	 	root	mean	square	of	the	successive	differences
Introduction
Postmenopausal women are at an increased risk for cardiovascular 
disease (CVD) [23]. Multiple risk factors such as hypertension and 
sedentary	lifestyle	can	lead	to	increases	in	proinflammatory	cy-
tokines and the development of atherosclerosis [28]. Two clinical 
measures of CVD are high plasma concentrations of C-reactive pro-
tein (CRP) [8], and heart rate variability (HRV), a noninvasive as-
sessment of autonomic nervous system (ANS) dysfunction [27]. 
The	inflammatory	response	in	CVD	has	been	shown	to	be	initiated	
by CRP in its dissociated form [44]. Further, reduced HRV indicates 
inadequate ANS response to stimuli and may augment cardiovas-
cular mortality [9]. In addition, HRV is a measure of the sympathet-
ic imbalance reflected by psychological stress common during 
menopause [37].
Endurance exercise training increases parasympathetic tone and 
provides a dose-response decrease in CRP that may contribute to 
the	anti-inflammatory	effects	of	exercise	[22].	While	HRV	declines	
with age, physically active women have higher HRV than sedentary 
women [7]. Reland et al. reported a vagal withdrawal in the highly 
active group compared to the low and moderate group, suggest-
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AbStr ACt
Postmenopausal women have an increased risk for cardiovascu-
lar disease through many factors, such as a sedentary lifestyle 
and reduced heart rate variability (HRV). Endurance training 
improves coronary risk but the role of exercise intensity is un-
clear. The purpose of this observational study was to evaluate 
the	effects	of	moderate	versus	vigorous	exercise	on	cardiovas-
cular disease risk in postmenopausal women. Thirty-six post-
menopausal women who self-reported training at moderate 
(3–5.9 METS; n = 18; age 58.9 ± 4.4yr) or vigorous intensities ( > 6 
METS; n = 18; age 59.7 ± 5.2yr) participated. C-reactive protein 
(CRP), HRV, VO2max, and stress (Perceived Stress Survey, Meno-
pause Rating Scale) were measured. Groups were compared 
using independent samples t-tests, and associations of exercise 
intensities with CRP and HRV were assessed using multiple re-
gression. CRP, HRV, and VO2max were similar (p > 0.05). Vigorous 
exercise had lower stress subscale scores (p < 0.01) and higher 
counter-stress subscale scores compared to moderate (p < 0.05). 
There was a positive association between time spent in vigorous 
exercise and HRV (p < 0.05).Vigorous exercise may not confer 
additional	benefits	in	CRP	and	HRV	over	moderate,	except	for	
stress reduction. However, more time spent in vigorous exercise 
was associated with higher HRV. Therefore, increased parasym-
pathetic tone may provide cardioprotection after menopause.
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ing that exercise intensity may enhance the sensitivity of the sinus 
node	and	therefore,	attenuate	the	effects	of	age	on	cardiovascular	
disease risk [35]. On the other hand, Sugawara et al. determined 
that moderate and vigorous physical activity exhibited equal ef-
fects	on	the	clinical	implications	of	central	arterial	stiffness	in	post-
menopausal women [41].
While	studies	on	the	effects	of	endurance	exercise	training	on	
younger athletes are prevalent [3], observational studies on the re-
lationship between exercise intensity and coronary risk in older 
women are limited and equivocal [47]. Therefore, the purpose of 
this	study	was	to	evaluate	the	effects	of	exercise	intensity	(moder-
ate versus vigorous) on cardiovascular disease risk in postmeno-
pausal	women.	We	hypothesized	that	older	women	who	trained	at	
a vigorous level will have increased HRV and lower CRP compared 
to those who trained at a moderate level, thus reducing their car-
diovascular disease risk.
Methods
Study design and participants
Thirty-six female postmenopausal (no menstruation previous 12 
months; surgical menopause allowed) volunteers were recruited. 
Participants self-reported their current exercise status as (1) Vig-
orous	training		≥	12	sessions/month	with	average	training	intensi-
ty		≥	6	METS	(VIG);	age	59.7	±	5.2yr;	or	(2)	moderate	intensity		≥	12	
sessions/month with average training intensity 3–5.9 METS (MOD); 
age	58.9	±	4.4yr	[24].	To	be	classified	in	the	VIG	group,	women	were	
required to be current competitive or masters swimmers, rowers, 
cyclists,	or	runners	(5–7	mph).	For	MOD	classification,	women	were	
recreational exercisers who participated in activities such as walk-
ing (3–4 mph), cycling (10–12 mph), or recreational swimming.
Assuming	an	effect	size	of.8	for	group	differences	in	the	stand-
ard	deviation	of	RR	intervals	(ms),	with	a	power	of	0.8	at	a	signifi-
cance	level	of	p	=	0.05,	we	calculated	a	sample	size	of	15	partici-
pants in each group using G * Power 3 (Germany) [11].
Exclusion criteria
Exclusion criteria were chronic disease (i. e., CAD, hypertension, 
cardiomyopathy,	diabetes,	severe	arthritis),	smoking,	β-blockers	
and antiarrhythmic drugs. Subjects with CRP values  > 10 mg/L were 
excluded from the analysis due to the likelihood of infectious or in-
flammatory	conditions	[29].	All	participants	had	one	or	fewer	CAD	
risk	factors	as	specified	by	ACSM	[24].	As	such,	no	physician	super-
vision was required for maximal exercise testing.
Procedures
The participants made one visit to the Exercise Physiology Labora-
tory at the university at least 24 h following their last regular exer-
cise bout. The participants refrained from ingesting food, alcohol, 
or	caffeine	within	three	hours	of	testing	[45].	Prior	to	this	visit,	they	
completed a health history questionnaire by telephone or email to 
verify	their	eligibility	for	study	inclusion.	Qualified	subjects	were	
emailed copies of the Menopause Rating Scale (MRS) [18] and Per-
ceived Stress Survey (PSS) [5] to be completed and brought to their 
laboratory visit. For the PSS, scores for “stress” (negative) and 
“counter-stress”	(positive)	were	analyzed	separately	[2].	The	MRS	
sums responses in three categories: somatic, psychological and 
urogenital.
The Institutional Review Board at the university approved the 
study protocol and it meets the ethical standards of the Interna-
tional	Journal	of	Sports	Medicine	[15].	Written	consent	was	ob-
tained from all participants.
Resting measurements
Following the completion of informed consent, a heart rate moni-
tor (Polar RS800cx, Finland) transmitter was placed on the partici-
pant’s chest and a receiver (watch) attached to their wrist. Subjects 
lay supine on a mat for measurement of resting HRV. After heart 
rate	stabilized	(~5	min),	RR	intervals	(time	subsequent	QRS	peaks)	
were recorded for 5 min with participants breathing normally [40]. 
Data	files	were	transferred	via	infrared	interface	and	checked	by	
the primary investigator for atypical beats using visual inspection 
and the algorithm within the Polar ProTrainer 5 Software (Polar 
Electro	Oy,	Kempele,	Finland).	Acceptable	data	files	were	trans-
ferred to HRV analysis software (Kubios HRV 2.1, Kuopio, Finland).
The HRV analysis included mean heart rate (HR), mean RR inter-
val, the root mean square of sequential deviations (RMSSD), and 
the percentage of all sequential RR deviations exceeding 50 ms 
(pNN50) in the time domain, plus high- (HF) and low- frequency 
(LF) power in the frequency domain [40].
Immediately following the HRV procedure, resting blood pres-
sure	(supine,	sitting)	was	measured.	Waist	circumferences	were	
measured and body fatness (BF %) was estimated using the sum of 
3	skinfolds	(triceps,	suprailiac,	thigh)	(Lange;	Cambridge	Scientific	
Products,	Cambridge,	MA,	USA).	Population-specific	equations	
were used to convert body density to percent body fat [20]. Fol-
lowing these measurements, height and weight were measured.
Subjects were then seated for the hs-CRP measurement. A lan-
cet	was	inserted	into	the	subject’s	finger	and	10	μL	of	whole	blood	
was obtained using a blood collection capillary. The capillary was 
inserted into a tube and shaken in order to draw the blood into the 
tube. Two drops of a reagent were applied to the sample and in-
serted into the holder of an iCHROMA reader (BODITECH MED INC., 
Chuncheon, Republic of Korea). The hs-CRP value was automati-
cally read and visible on the screen in three minutes. The iCHROMA 
reader	has	been	shown	to	have	significant	correlations	with	both	
the immunoturbidimetry (r = 0.988) and immunonephelometry 
(r = 0.989) methods, as well as intra- and interassay CVs of  < 3 % 
and  < 5 %, respectively [32].
Aerobic capacity
Maximum oxygen consumption (VO2max) was determined using 
the Bruce protocol. The speed and grade of the treadmill (Quinton 
TM55,	Cardiac	Science,	Waukesha,	WI,	USA)	were	increased	every	
three minutes until indications for terminating exercise testing as 
specified	by	the	American	College	of	Sports	Medicine	(ACSM)	were	
present, e. g., subject’s desire to stop, signs of poor perfusion, drop 
in systolic blood pressure  > 10 mm Hg from baseline [45]. Expired 
gases were collected continuously using a calibrated metabolic cart 
(ParvoMedics True Max 2400, Sandy, UT, USA). Heart rate (Polar) 
was monitored throughout exercise testing, while exercise blood 
pressures and rating of perceived exertion were recorded every 
3 min. Following the exercise test, subjects walked at a self-select-
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ed	pace	(2.0	mph)	for	five	minutes.	Recovery	heart	rate	was	record-
ed at minutes 1 and 2 and 5.
Exercise intensity measures and energy expenditure
To objectively quantify current exercise training intensity, subjects 
were lent a heart rate monitor (Polar RCX5) to wear during three 
typical workouts of their exercise routine. Participants were in-
structed not to change or modify their exercise program, only to 
exercise as normal. For consistency, participants were encouraged 
to complete the 3 workouts in the following 2 weeks. Three days 
of monitoring were selected based on previous research and sub-
ject	convenience	[16].	Watches	were	programmed	based	on	max-
imal HR data from the VO2max	test.	Classification	of	physical	activ-
ity intensities were “light” (50–63 %), “moderate” (64–76 %), “vig-
orous/hard” (77–93 %), “vigorous/very hard” (94–99 %) and 
“maximal” (100 % HRmax)	as	specified	by	ACSM	[45].	Participants	
were given instruction on HR monitor operation and practiced prior 
to leaving the laboratory. Heart rate monitors were returned by 
mail.
Heart	rate	data	was	transferred	via	Polar	WebSync	(v2.7)	soft-
ware for analysis. Caloric expenditures were calculated from the 
metabolic equivalents using the 2011 Compendium of Physical Ac-
tivities [1]. The METS for each activity were converted to 
kcal	∙	kg	−	1	∙	hr	−	1	(1MET	=	1	kcal	∙	kg	−	1	∙	hr	−	1) and multiplied by each 
subject’s body mass in kg. Caloric expenditure per minute was cal-
culated by dividing this amount by 60 min [20].
Statistical analysis
Student’s independent t-tests were used to compare the outcome 
variables between the two levels of exercise intensity. Associations 
between HRV or CRP as the dependent variable and exercise inten-
sity as the independent variable were assessed using multiple re-
gression (method: enter). Menopause years and BMI were con-
trolled	for	due	to	their	influence	on	HRV	measurements	[37].	There	
were	five	participants	in	the	MOD	group	taking	hormone	therapy	
(HT) and one in VIG. Therefore, the CRP and HRV values were ana-
lyzed	with	and	without	the	participants	who	were	on	HT.	Previous	
research from Harvey et al. (2015) reported a lack of improvement 
in HRV following estrogen therapy [17]. Chi square was used to de-
termine	group	differences	for	HT.
Normality	was	checked	with	the	Shapiro-Wilk	test.	Variables	
with a skewed distribution were log-transformed prior to analysis. 
The	level	of	significance	was	set	a	p	<	0.05.	Statistical	analyses	were	
performed using IBM SPSS Statistics 20.0.
Results
▶table 1 shows the participant characteristics. Of the 18 women in 
the VIG group, there were 13 master swimmers, 2 competitive row-
ers, 2 cyclists and 1 runner. The MOD group had 14 recreational swim-
mers, 1 runner, and 3 women who worked out at the gym (elliptical, 
walking).	The	VIG	group	had	significantly	higher	values	for	waist	cir-
cumference (81.3 ± 9.6 cm vs. 74.1 ± 5.0 cm; p < 0.01), resting supine 
SBP (120.8 ± 11.8 mm Hg vs. 106.7 ± 9.7 mm Hg; p < 0.001), resting 
sitting SBP (119.1 ± 16.5 mm Hg vs. 105.0 ± 10.0 mm Hg, p < 0.001), 
as well as sitting DBP (72.5 ± 11.5 mmHg vs. 64.4 ± 7.3 mm Hg; 
p < 0.05). The menopausal age of the moderate and vigorous groups 
were 7.5 ± 3.8yr and 8.1 ± 5.9yr, respectively (p > 0.05).
▶table 2 gives the group comparisons for the VO2max testing. 
The VIG group performed longer during the treadmill test 
(11.6 ± 2.6 min vs. 10.5 ± 2.2 min; ES = 0.46) and had a slightly high-
er VO2max (34.5 ± 5.1 ml/kg/min vs. 32.4 ± 5.7 ml/kg/min; 
ES = 0.39), but these measurements did not reach statistical signif-
icance (p > 0.05). ▶table 3 shows the group comparisons for HRV 
at rest. Although VIG had higher values for most measurements, 
there were no significant differences between the two groups. 
When	the	data	from	the	participants	who	were	taking	HT	were	re-
moved,	there	also	were	no	significant	differences	between	the	HRV	
values (p > 0.05).
For	the	stress	variables,	the	PSS	showed	that	VIG	had	significant-
ly lower stress (6.11 ± 2.95 vs. 9.69 ± 4.36) and higher counter-
stress (13.61 ± 1.88 vs. 11.72 ± 2.37) compared to MOD (p < 0.05). 
For the MRS values, VIG had a sum of 8.3 ± 6.1, whereas MOD had 
10.9 ± 4.6 (p > 0.05).
For group comparisons of the workout data, the VIG group ex-
pended	significantly	higher	average	kcal	(487.9	±	163.9	kcal	vs.	
▶table 1  Participant Characteristics.
Moderate  
(MOD; n = 18)
Vigorous  
(VIG; n = 18)
P value
Age (yr) 58.9 ± 4.4 59.7 ± 5.2 0.60
BMI (kg/m2) 23.0 ± 2.7 24.6 ± 3.0 0.13
SBP (supine; mm Hg) 106.7 ± 9.7 120.8 ± 11.8 0.001
DBP (supine; mm Hg) 68.1 ± 6.4 73.4 ± 11.5 0.1
SBP (seated; mm Hg) 105.0 ± 10.0 119.1 ± 16.5 0.004
DBP (seated; mm Hg) 64.4 ± 7.3 72.5 ± 11.5 0.017
WC	(cm) 74.1 ± 5.0 81.3 ± 9.6 0.008
BF ( %) 23.8 ± 4.7 24.5 ± 3.9 0.65
RHR 62.8 ± 5.9 59.9 ± 8.7 0.25
CRP (mg/L) 1.1 ± 2.0 0.43 ± 0.33 0.22
HT ( %) 6 28 0.36
All values are mean ± SD; unadjusted values; MOD, trained at 3.0–5.9 
METS;	VIG,		≥	6.0	METS;	BMI,	body	mass	index;	SBP,	systolic	blood	
pressure;	DBP,	diastolic	blood	pressure;	WC,	waist	circumference;	BF,	
body fat; RHR, resting heart rate; CRP, C-reactive protein; HT, hormone 
therapy.
▶table 2  Treadmill VO2max Testing.
Moderate 
(MOD; n = 18)
Vigorous  
(VIG; n = 18)
P value
VO2max (ml/kg/min) 32.4 ± 5.7 34.5 ± 5.1 0.24
RPEmax 17.8 ± 1.6 18.0 ± 1.4 0.66
RERmax 1.23 ± 0.10 1.24 ± 0.11 0.75
Test duration (min) 10.5 ± 2.2 11.6 ± 2.6 0.15
HRmax (bpm) 163.9 ± 10.6 162.1 ± 10.9 0.60
HR recovery min 1 (bpm) 24.4 ± 9.3 22.7 ± 9.0 0.85
All values are mean ± SD; VO2max, maximal uptake of oxygen, directly 
measured; RPE, rating of perceived exertion; RER, respiratory exchange 
ratio; HR, heart rate.
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292.8 ± 157.6 kcal; p < 0.01) over the three workouts. There were 
no	significant	differences	between	the	groups	for	average	minutes	
spent exercising “hard” (22.7 ± 11.9 vs 22.17.7 ± 14.2 min) or mod-
erately (22.3 ± 20.9 vs 20.0 ± 15.2 min) for VIG and MOD, respec-
tively (p > 0.05).
Since	there	was	no	significant	difference	for	total	minutes	exer-
cising at each intensity, for the multiple regression analysis we 
pooled the data for overall minutes (collapsed data by group). Con-
trolling	for	BMI	and	menopause	years	improved	the	fit	of	both	of	
these models. For SDNN and rMSSD, the prediction models were 
statistically	significant,	(p	<	0.01,	p	<	0.05,	respectively),	with	total	
minutes of hard exercise (77–93 % HRmax) showing a positive 
(healthy) association with HRV indices (▶table 4).
Discussion
This observational study showed that vigorous exercise was simi-
lar	to	moderate	exercise	in	terms	of	cardiovascular	disease	risk.	We	
also demonstrated that more time spent performing vigorous ex-
ercise, regardless of group, resulted in higher select HRV indices. 
The	women	in	the	VIG	group	benefited	however,	from	their	intense	
training with improvements in stress management.
We	found	that	more	time	spent	exercising	at	a	higher	level	im-
proved both SDNN and rMSSD, both time domain measures of HRV. 
As women age, they are at increased risk for cardiovascular disease 
as	the	reduced	HRV	reflects	an	increased	dependence	on	the	sym-
pathetic nervous system [26]. Accordingly, the risk of malignant 
arrhythmias	increase	as	the	protective	effect	of	vagal	activity	has	
been compromised [39]. Recently, high-intensity interval training 
(85–95 % HRmax) for 12 weeks was found to be superior to mod-
erate training for SDNN, representing enhanced vagal modulation 
[34].
It is important to mention that our participants’ cardiovascular 
risk	profiles	reflected	their	training,	with	healthy	values	for	CRP,	
body fat and blood pressure. Healthy CRP levels are essential 
through and beyond menopause due to their potential involvement 
in the transition to from subclinical to clinical disease [25]. It was 
not	surprising	in	the	present	study	to	find	that	the	VIG	group	had	
significantly	higher	(although	healthy	values)	SBP,	DBP	and	WC	
compared to MOD. The majority of the women in the VIG group 
were competitive and masters swimmers who raced in open water. 
Previous studies have shown that regular swimming can elevate 
blood	pressure	[6].	Additionally,	swimming	is	not	as	effective	in	re-
ducing body fat or weight, compared to running or walking [43].
Several studies have shown the importance of exercise in stress 
management. Gerber et al. reported that meeting ACSM’s guide-
lines for vigorous activity resulted in lower amounts of stress, pain, 
depression and sleep disturbances [14]. Importantly, these bene-
fits were superior to those reported in the moderately trained 
group. In a study on older adults ( > 65yr) by Marcellini et al., those 
reporting reduced levels of PA had subsequently higher depression 
(Geriatric Depression Scale) and PSS scores [31]. Both moderate 
and vigorous exercise has been shown to improve major depres-
sive disorder [38]. In the present study, although there was no sig-
nificant	difference	in	VO2max between the groups, the VIG women 
had	mean	values	(34.5	ml	∙	kg	−	1	∙	min	−	1) that were ranked in the 
“good” category for 50–59yr according to ACSM [24]. An increased 
level	of	cardiorespiratory	fitness	has	been	shown	to	offset	the	det-
rimental	effects	of	the	aging-psychological	stress	combination	on	
the hypothalamic-pituitary-adrenal axis [46], thus further increas-
ing	susceptibility	of	inflammatory	diseases	in	older	adults	[19].
Not all studies have shown a clear benefit of high-intensity 
exercise. Campbell et al. reported no decrease in CRP following 12 
months of moderate-vigorous aerobic exercise training in men 
and women 40–75 years [4]. Manson et al. found an equal risk 
reduction of nearly 30 % in walkers and women who exercised at a 
high level [30]. Pavey et al. concluded that there was no additional 
benefit to adding vigorous exercise except at the  > 2000 
▶table 3  Resting HRV.
Moderate  
(MOD; n = 18)
Vigorous  
(VIG; n = 18)
MEANRR 6.85 ± 0.09 6.90 ± 0.14
SDNN 3.41 ± 0.48 3.41 ± 0.38
RMSSD 3.20 ± 0.51 3.34 ± 0.43
pNN50 1.72 ± 1.06 1.94 ± 1.08
LF (ms2) 6.06 ± 1.10 6.16 ± 1.01
HF (ms2) 5.08 ± 0.93 5.47 ± 0.82
LF (nu) 4.16 ± 0.35 4.11 ± 0.28
HF (nu) 3.19 ± 0.88 3.42 ± 0.78
LFHF ratio 0.97 ± 1.19 0.68 ± 1.02
All values are mean ± SD and are log-transformed; p > 0.05 for all 
comparisons; Time domain: MEANRR, mean RR interval; SDNN, 
standard deviation of all normal RR intervals; RMSSD, root mean 
square of sequential deviations; pNN50, percentage of all sequential 
RR deviations exceeding 50 ms; Frequency domain: LF, low 
frequency;	HF,	high	frequency;	nu,	normalized	units;	ms2, absolute 
units.
▶table 4  Multiple regression models evaluating the association with HRV variables with exercise intensities.
Dependent variable Predictor Adjusted R2 Unstandardized 
coefficient
Standardized 
coefficient
P value
lnSDNN Hard PA 0.288 0.011 0.349 0.03
Mod PA 	−	0.002 	−	0.102 0.50
lnCRP Hard PA 0.182 0.023 0.308 0.066
Mod PA 0.007 0.120 0.46
lnRMSSD Hard PA 0.219 0.014 0.386 0.02
Mod PA 	−	0.002 	−	0.080 0.62
SDNN, standard deviation of all normal RR intervals; CRP, C-reactive protein; RMSSD, root mean square of sequential deviations; ln, logarithmically 
transformed; Hard PA, physical activity at 77–93 % HRmax; Mod PA, physical activity at 64–76 % HRmax.
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MET	∙	min	∙	wk	−	1 level [33]. Recently, Roxburgh et al. compared the 
cardiorespiratory	fitness	values	following	12	weeks	of	moderate	or	
moderate  +  high-intensity interval training [36]. Although the re-
sults	were	equivocal	as	to	the	added	benefits	of	high	intensity	ex-
ercise, the combined group had a 1 MET increase in cardiorespira-
tory	fitness	following	the	training.	Previous	research	has	shown	that	
this increase could reduce the likelihood of CVD by 8–17 % [42].
The current ACSM position stand for quantity and quality of ex-
ercise	specifies	adding	vigorous	exercise	(	≥	20	min	·	d	on		≥	3	d	·	wk	
(	≥	75	min	·	wk)	or	a	combination	of	moderate	and	vigorous	exer-
cise to one’s training program [13]. Perhaps, as suggested by Sug-
awara et al., cardioprotection can result from an interaction of the 
two intensities [41]. It is also possible that the women in the pre-
sent study achieved a “threshold” level in their arterial function 
through their lifetime commitment to physical activity and train-
ing [10]. The importance of exercise in chronic disease prevention 
throughout the lifespan cannot be overstated. In a recent large ob-
servational study using NHANES data, Fishman et al. reported that 
moderate-intensity exercise was associated with lower mortality 
but	pointed	out	that	there	were	considerable	benefits	even	from	
moving from a sedentary lifestyle to a program of low-intensity ex-
ercise [12].
There	are	some	limitations	to	our	study.	First,	our	sample	size	
was small due to the strict inclusion and exclusion criteria. Our sam-
ple	of	participants	is	not	reflective	of	the	general	population,	which	
limited	our	ability	to	generalize	our	findings.	As	such,	these	results	
can	be	generalized	only	to	women	who	were	highly	motivated	to	
train and compete in settings that provided a network of teamwork 
and support, regardless of intensity level. Secondly, we also would 
have	benefited	from	a	sedentary	control	group.	However,	previous	
studies have reported improved cardiometabolic biomarkers with 
moderate and vigorous exercise over light [21]. Third, we found it 
important for our participants to maintain their current exercise 
routine during the objective measurements of intensity. Still, some 
women	possibly	overestimated	their	training	efforts	at	the	time	of	
enrollment, whereas others underestimated. Using the 6 MET as a 
cut-off	between	moderate	and	vigorous	intensity	was	specified	by	
ACSM [45]. Many of our moderate level participants trained at the 
high end (i. e., 6 METS for “bay swimming”), whereas some of the 
vigorous level participants trained at the low end (i. e., 3.3 METS 
for “walking 2.5 mph”). Although 75 % of our participants were 
swimmers, it is a limitation that we included other exercise modes 
as well. It is important to note, however, that all women were en-
durance	trained	for	a	minimum	of	6	months.	We	did	not	recruit	
strength-trained or racket athletes. Fourth, the women used self-
ratings	for	the	PSS	and	MRS,	which	only	reflected	their	current	psy-
chological state and not an average.
Overall,	our	findings	suggest	that	vigorous	exercise	may	be	ben-
eficial	for	stress	reduction	and	improved	heart	rate	variability.	Spe-
cifically,	more	time	spent	exercising	at	a	vigorous	level,	with	or	
without formal interval training, is associated with improved auto-
nomic	function.	Although	no	significant	differences	were	found	be-
tween	MOD	and	VIG,	exercise	guidelines	as	specified	by	ACSM	state	
the importance of adding vigorous exercise (either alone or in com-
bination with moderate exercise) to develop and maintain cardi-
orespiratory health throughout the aging process.
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